TrialJournal of acquired immune deficiency syndromes (1999)2012

Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety.

Anna-Barbara Moscicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.